In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Non-troponin biomarkers in acute coronary syndromes
Session

Congress : ESC Congress 2019

Topic : Acute Coronary Syndromes: Biomarkers

  • Session type : Abstract Session
  • Date : 01 September 2019
  • Time : 14:30 - 15:40

5 presentations in this session

Apoptotic and non-apoptotic circulating microparticles in patients with acute coronary syndromes

Congress : ESC Congress 2019

  • Session : Non-troponin biomarkers in acute coronary syndromes
  • Speaker : A Antonopoulos (Athens,GR)

Results from the CAMI1 Study: Selective CRP apheresis as a new treatment option in acute myocardial infarction

Congress : ESC Congress 2019

  • Session : Non-troponin biomarkers in acute coronary syndromes
  • Speaker : C Garlichs (Flensburg,DE)

HsCRP predicts mortality beyond troponin in 102,337 patients with suspected acute coronary syndrome (CRP-RISK study)

Congress : ESC Congress 2019

  • Session : Non-troponin biomarkers in acute coronary syndromes
  • Speaker : A Kaura (London,GB)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are